Advertisement

Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Focus on Optimized Dosing of Ibrutinib Panel Discussion

David A. Hyman, MD, JD, on Inclusive Shared Savings

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Advertisement

Advertisement




May
03
Today In Oncology
Risk of Arterial Thromboembolism in Japanese Patients With Cancer
Breast Implant–Related Cancers: Should Our Patients Be Concerned?
Metastatic Urothelial Cancer NECTIN4 Amplification and Response to Enfortumab Vedotin
Salvage Reirradiation for Locally Recurrent Prostate Cancer 7-Year Follow-up
Effect of Mindfulness Audio Recordings on Physical Emotional Side Effects During Radiation Therapy for Prostate Cancer
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside